youtube_live
Q2 2027 earnings • released • EPS beat +၁၅.၀၃% • Revenue beat +၆.၃၅%
See resultschevron_right
EMCURE:NSE
Emcure Pharmaceuticals Ltd
၂,၂၃၃.၀၀ ₹
arrow_upward
+၃.၃၆%(+၇၂.၆၀) 1D
နို ၅, GMT+၅:၃၀ ၁၅:၃၀:၀၀ · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
၂,၁၇၉.၀၀ ₹
High
၂,၂၆၆.၄၀ ₹
Low
၂,၁၄၃.၀၀ ₹
Mkt. cap
ဋေ ၄.၂၂ သ
Avg. vol.
၁.၆၂ သိန်း
Volume
၅.၃၆ သိန်း
Dividend
၀.၁၆%
Quarterly dividend
၀.၉၀ ₹
Ex-dividend date
၂၀၂၆ စက် ၄
P/E ratio
၄၁.၈၆
52-wk high
၂,၂၆၆.၄၀ ₹
52-wk low
၁,၃၁၂.၃၀ ₹
EPS
၅၃.၃၅ ₹
No. of employees
၇ ထောင်
Open
၂,၁၇၉.၀၀ ₹
High
၂,၂၆၆.၄၀ ₹
Low
၂,၁၄၃.၀၀ ₹
Mkt. cap
ဋေ ၄.၂၂ သ
Avg. vol.
၁.၆၂ သိန်း
Volume
၅.၃၆ သိန်း
Dividend
၀.၁၆%
Quarterly dividend
၀.၉၀ ₹
Ex-dividend date
၂၀၂၆ စက် ၄
P/E ratio
၄၁.၈၆
52-wk high
၂,၂၆၆.၄၀ ₹
52-wk low
၁,၃၁၂.၃၀ ₹
EPS
၅၃.၃၅ ₹
No. of employees
၇ ထောင်
News stories
From web sources and news partners
Yahoo Finance
·
ပြီးခဲ့သည့် ၅ နာရီ
Emcure Pharmaceuticals Ltd (BOM:544210) (Q2 2027) Earnings Call Highlights: Revenue Jumps 24% ...
Investing.com
·
ပြီးခဲ့သည့် ၂ ရက်
Emcure Q2FY27 slides: profit growth outpaces revenue on margin gains
Investing.com
·
ပြီးခဲ့သည့် ၂ ရက်
Earnings call transcript: Emcure lifts FY27 outlook as Q2 profit jumps
TradingView
·
ပြီးခဲ့သည့် ၂ ရက်
EMCURE: Q2 growth accelerated across revenue and earnings, led by a 34.5% rise in international sales
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees၆.၉၁ ထောင်
Founded၁၉၈၁ ဧ ၁၆
Headquarters-
Sector-
Industry-
Websiteemcure.com